1. Home
  2. BWXT vs PODD Comparison

BWXT vs PODD Comparison

Compare BWXT & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

HOLD

Current Price

$206.44

Market Cap

18.0B

Sector

N/A

ML Signal

HOLD

Logo Insulet Corporation

PODD

Insulet Corporation

HOLD

Current Price

$241.89

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWXT
PODD
Founded
1867
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.0B
21.0B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
BWXT
PODD
Price
$206.44
$241.89
Analyst Decision
Buy
Buy
Analyst Count
9
22
Target Price
$202.93
$352.86
AVG Volume (30 Days)
826.8K
1.1M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
0.48%
N/A
EPS Growth
N/A
N/A
EPS
2.57
3.48
Revenue
$1,687,738,000.00
$2,708,100,000.00
Revenue This Year
$18.99
$22.19
Revenue Next Year
$16.44
$18.68
P/E Ratio
$81.19
$71.53
Revenue Growth
N/A
30.73
52 Week Low
$84.21
$230.08
52 Week High
$220.57
$354.88

Technical Indicators

Market Signals
Indicator
BWXT
PODD
Relative Strength Index (RSI) 56.96 35.41
Support Level $193.28 $240.78
Resistance Level $209.22 $275.10
Average True Range (ATR) 8.87 9.66
MACD 0.10 0.90
Stochastic Oscillator 83.53 4.17

Price Performance

Historical Comparison
BWXT
PODD

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Share on Social Networks: